Abstract:The emerging clinical success of checkpoint blockade immunotherapy in human cancer patients has highlighted the critical importance of PD-L1, a ligand for the T cell inhibitory receptor PD-1, as a molecular target in cancer immunotherapy. PD-L1 is constitutively expressed in tumor cells and is also inducible by inflammatory cytokines such as IFNgamma. It has been proposed that tumor cells may sense the elevated IFNgamma from activated host T cells as a “threat” in the tumor microenvironment and adapt it by up-regulating PD-L1. The aim of this study is to elucidate the molecular mechanism underlying IFNgamma regulation of PD-L1 expression in tumor cells. We observed that PD-L1 is constitutively expressed, albeit at low level, in multiple types of cancer cells, including pancreatic, colon, breast, and sarcoma cells. IFNgamma treatment dramatically increased PD-L1 expression level and IFNgamma up-regulates PD-L1 expression through the Jak-STAT1 signaling pathway in vitro and in vivo. Chromatin immunoprecipitation assay did not identify IFNgamma-activated pSTAT1 binding to the pd-l1 promoter. Instead, we observed that IFNgamma activates IRF1 transcription and IRF1 is required for IFNgamma-induced PD-L1 expression. Chromatin immunoprecipitation analysis shows that pSTAT1 is associated with the irf1 but not the pd-l1 promoter. Analysis of the irf1 promoter DNA sequence revealed a pSTAT1-binding consensus sequence, and electrophoretic mobility shift assay indicates that pSTAT1 directly binds to this DNA element of the irf1 promoter. Furthermore, we demonstrated that IRF1 is associated with the pd-l1 promoter chromatin near the irf1 transcription initiation site. The pd-l1 promoter region contains a putative IRF1-binding consensus sequence and electrophoretic mobility shift assay shows that IRF1 binds to this DNA element of the pd-l1 promoter region. Taken together, our data indicate that IFNgamma activates pSTAT1 that binds to the irf1 promoter to activate irf1 transcription. IFNgamma-induced IRF1 then binds to the pd-l1 promoter to activate pd-l1 transcription in tumor cells. Citation Format: Chunwan Lu, Amy V. Paschall, Priscilla S. Redd, Iryna Lebedyeva, Kebin Liu. IFNgamma regulates PD-L1 expression through activating IRF1 transcription in tumor cells. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 2327.

Interferon-Gamma Upregulates Expression Of Ifp35 Gene In Hela Cells Via Interferon Regulatory Factor-1

Ifr-9/Stat2 Functional Interaction Drives Retinoic Acid-Induced Gene G Expression Independently Of Stat1

IFI35 Promotes Renal Cancer Progression by Inhibiting pSTAT1/pSTAT6-Dependent Autophagy

IFI35 is involved in the regulation of the radiosensitivity of colorectal cancer cells

IFP35 Is a Relevant Factor in Innate Immunity, Multiple Sclerosis, and Other Chronic Inflammatory Diseases: A Review

Differential Regulation of Interleukin (IL)-12 P35 and P40 Gene Expression and Interferon (Ifn)-Γ–primed IL-12 Production by IFN Regulatory Factor 1

IFP35 is involved in the antiviral function of interferon by association with the viral tas transactivator of bovine foamy virus.

Abstract 2327: IFNgamma Regulates PD-L1 Expression Through Activating IRF1 Transcription in Tumor Cells

Ifngamma Regulates Pd-L1 Expression Through Activating Irf1 Transcription In Tumor Cells

A Novel Mechanism Underlying the Expression Regulation of an IFN-Inducible Gene RIG-G

IFI44L expression is regulated by IRF-1 and HIV-1

Interferon-inducible protein IFI35 negatively regulates RIG-I antiviral signaling and supports vesicular stomatitis virus replication

IL-35 over-expression increases apoptosis sensitivity and suppresses cell growth in human cancer cells

Sequential Activation Of Protein Kinase C Delta And Jnk Is Required For Interferon-Alpha-Induced Expression Of Ifit4

A Critical Role of Interferon-Induced Protein Ifp35 in the Type I Interferon Response in Cells Induced by Foot-And-Mouth Disease Virus (fmdv) Protein 2C

Synergistic Activation of Interleukin-12 P35 Gene Transcription by Interferon Regulatory Factor-1 and Interferon Consensus Sequence-Binding Protein

Tumor-Derived Il-35 Promotes Tumor Growth by Enhancing Myeloid Cell Accumulation and Angiogenesis

Expression of Interferon Regulatory Factor 5 is Regulated by the Sp1 Transcription Factor.

Molecular Identification and Transcriptional Regulation of Porcine IFIT2 Gene

Reduction in P48-Isgfgamma Levels Confers Resistance to Interferon-Alpha2a in MHCC97 Cells.

Sequential Activation of Protein Kinase C Δ and JNK is Required for Interferon-Α-induced Expression of IFIT4